abstract |
The invention generally relates to pharmaceutical uses of lanosta-8,24-dien-3-ols, a family of tetracyclic terpenoles, as anti-inflammatory, anticancer and analgesic agents by inhibiting the disordered activation of serine-threonine kinase proteins , particularly PKC. |